Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An LNP-CRISPR gene editing drug demonstrates efficacy and safety in patients with hereditary angioedema following in vivo administration

24 Jun 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 38925443
DOI: 10.1016/j.jaci.2024.06.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An LNP-CRISPR gene editing drug demonstrates efficacy and safety in patients with hereditary angioedema following in vivo administrationPMID 38925443Read ↗

IN VIVO CRISPR/CAS9 EDITING OF KLKB1 IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A FIRST-IN-HUMAN STUDYSemantic proximity Read ↗

CRISPR-Based Therapy for Hereditary AngioedemaSemantic proximity Read ↗

CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary AngioedemaSemantic proximity Read ↗

A systematic review of gene editing clinical trialsSemantic proximity Read ↗

The Future of Gene Therapy: A Review of In Vivo and Ex Vivo Delivery Methods for Genome Editing-Based TherapiesSemantic proximity Read ↗

In vivo LNP-CRISPR Approaches for the Treatment of HemophiliaSemantic proximity Read ↗

Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous diseaseSemantic proximity Read ↗

Drug delivery systems for CRISPR-based genome editorsSemantic proximity Read ↗

Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells.Semantic proximity Read ↗

Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytesSemantic proximity Read ↗

Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a HighlightSemantic proximity Read ↗

Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.